Abstract
It has been recently shown that insulin has a neuroprotective effect. Experimental studies and clinical trials have demonstrated that insulin is a promising drug for treatment of neurodegenerative and other diseases associated with brain damage. However, the mechanism of the neuroprotective effect of insulin is far from being elucidated. The aim of this study was to examine the dependence of the protective effect of insulin in cortical neurons on its concentration and the involvement of the modulation of the activity of extracellular signal-regulated kinase (ERK1/2) by insulin in neuronal survival. Using the MTT method, we found that the protective effect of insulin in neurons treated with hydrogen peroxide varied in the concentration range of 1–100 nm (1 nM < 10 nM < 100 nM). There were no significant differences between the effects of 100 nM or 1 nM insulin. The literature data on the effects of insulin on the activity of ERK1/2 in neurons are controversial. We studied the modulatory effect of insulin on the activity of ERK1/2 in cortical neurons during development of oxidative stress using the immunoblotting method at eight time points after prooxidant application. We found that insulin increased the basal activity of ERK1/2 and the activity of the enzyme at the early stage of action of hydrogen peroxide, that is, 5–30 min after its addition. This may improve the protective effect of insulin.
References
Miller, E.R., Pastor-Barriuso, R., Dalal, D., Riemersma, R., Appel, L.J., and Guallar, E., Ann. Intern. Med., 2005, vol. 142, pp. 37–46.
Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., and Gluud, C., J. Amer. Med. Association, 2007, vol. 297, pp. 842–857.
Bjelakovic, G., Nikolova, D., and Gluud, C., PLoS One, 2013, vol. 8, no. 9: e74558.
Duarte, A.I., Santos, P., Oliveira, C.R., Santos, M.S., and Rego, A.C., Biochim. Biophys. Acta, 2008, vol. 1783, pp. 994–1002.
Ramalingam, M. and Kim, S.J., J. Recept. Signal Transduct., Res., 2015, vol. 35, pp. 1–7.
Sukhov, I.B., Shipilov, V.N., Chistyakova, O.V., Trost, A.M., and Shpakov, A.O., Dokl. Akad. Nauk, 2013, vol. 453, no. 5, pp. 577–580.
Shpakov, A.O., Derkach, K.V., and Berstein, L.M., Future Science OA (FSO), 2015, vol. 1, no. 3: FSO25. doi 10.4155/fso.15.23
Claxton, A., Baker, L.D., Hanson, A., Trittschuh, E.H., Cholerton, B., Morgan, A., Callaghan, M., Arbuckle, M., Behl, C., and Craft, S., J. Alzheimer’s Dis., vol. 44, no. 3, pp. 897–906.
Shah, A.K., Gupta, A., and Dey, C.S., AICAR Arch. Biochem. Biophys., 2011, vol. 509, pp. 142–146.
Dichter, M.A., Brain Res., 1978, vol. 149, pp. 279–293.
Mironova, E.V., Evstratova, A.A., and Antonov, S.M., J. Neurosci. Methods, 2007, vol. 163, pp. 1–8.
Hansen, M.B., Nielsen, S.E., and Berg, K.J., Immunol. Methods, 1989, vol. 119, pp. 203–210.
Zakharova, I.O., Sokolova, T.V., Bayunova, L.V., Vlasova, Y.A., Rychkova, M.P., and Avrova, N.F., Int. J. Mol. Sci., 2012, vol. 13, pp. 11543–11668.
Duarte, A.I., Santos, M.S., Oliveira, C.R., and Rego, A.C., Free Rad. Biol. Med., 2005, vol. 39, pp. 876–889.
Ryu, B.R., Ko, H.W., Jou, I., Noh, J.S., and Gwag, B.J., J. Neurobiol., 1999, vol. 39, pp. 536–546.
Hui, L., Pei, D.-S., Zhang, Q.-G., Guan, Q.-H., and Zhang, G.-Y., Brain Res., 2005, vol. 1052, pp. 1–9.
Kim, L., Pei, D.-S., Zhang, Q-G., Guan, Q.-H., and Zhang, G.-Y., Antioxid. Redox Sign., 2011, vol. 14, pp. 1829–1839.
Sui, Z., Kovacs, A.D., and Maggirwar, S.B., Biochem. Biophys. Res. Commun., 2006, vol. 345, pp. 1643–1648.
Filippi, B.M., Yang, C.S., Tang, C., and Lam, T.K., Cell Metab., 2012, vol. 16, pp. 500–510.
Kong, D., Gong, L., Arnold, E., Shanmugam, S., Fort, P.E., Gardner, T.W., and Abcouwer, S.F., Exp. Eye Res., 2015, vol. 151, pp. 83–95.
Ziegler, C.G., Sicard, F., Sperber, S., Ehrhart-Bornstein, M., Bornstein, S.R., and Krug, A.W., Ann. NY Acad. Sci., 2006, vol. 1073, pp. 306–311.
Vauzour, D., Vafeiadou K., Rice-Evans, C., Williams, R.J., and Spencer, J.P, J. Neurochem., 2007, vol. 103, pp. 1355–1367.
Zakharova, I.O., Sokolova, T.V., Vlasova, Y.A., Furaev, V.V., Rychkova, M.P., and Avrova, N.F., Neurochem. Res., 2014, vol. 39, pp. 2262–2275.
Namura, S., Iihara, K., Takami, S., Nagata, I., Kikuchi, H., Matsushita, K., Moskowitz, M.A., Bonventre, J.V., and Alessandrini, A., Proc. Natl. Acad. Sci. U.S.A., 2001, vol. 98, pp. 11569–11574.
Lu, K., Liang, C.L., Liliang, P.C., Yang, S.-H., Cho, C.L., Weng, H.C., Tsai, Y.-D., Wang, K.W., and Chen, H.J., J. Neurochem., 2010, vol. 114, pp. 237–246.
Zakharova, I.O., Sokolova, T.V., Vlasova, Y.A., Bayunova, L.V., Rychkova, M.P., and Avrova, N.F, Int. J. Mol. Sci., 2017, vol. 18, no. 1:216.
Kulebyakin, K., Karpova, L., Lakonsteva, E., Krasavin, M., and Boldyrev, A., Amino Acids, 2012, vol. 43, pp. 91–96.
Luo, Y. and DeFranco, D.B., J. Biol. Chem., 2006, vol. 281, pp. 16436–16442.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.I. Zorina, L.V. Bayunova, I.O. Zakharova, N.F. Avrova, 2018, published in Neirokhimiya, 2018, Vol. 35, No. 1, pp. 101–106.
Rights and permissions
About this article
Cite this article
Zorina, I.I., Bayunova, L.V., Zakharova, I.O. et al. The Dependence of the Protective Effect of Insulin on Its Concentration and Modulation of ERK1/2 Activity under the Conditions of Oxidative Stress in Cortical Neurons. Neurochem. J. 12, 111–116 (2018). https://doi.org/10.1134/S1819712417040110
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712417040110